This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1991 Nov-Dec;1(1):91-4.

Testing for germ line p53 mutations in cancer families

F P Li¹, P Correa, J F Fraumeni Jr

Affiliations

PMID: 1845175

Testing for germ line p53 mutations in cancer families

F P Li et al. Cancer Epidemiol Biomarkers Prev. 1991 Nov-Dec.

. 1991 Nov-Dec;1(1):91-4.

Authors

F P Li¹, P Correa, J F Fraumeni Jr

Affiliation

¹ Epidemiology and Biostatistics Program, National Cancer Institute, Bethesda, Maryland 20892.

PMID: 1845175

Erratum in

Cancer Epidemiol Biomarkers Prev 1992 May-Jun;1(4):335

No abstract available

PubMed Disclaimer

Similar articles

Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome.
Frebourg T, Barbier N, Yan YX, Garber JE, Dreyfus M, Fraumeni J Jr, Li FP, Friend SH. Frebourg T, et al. Am J Hum Genet. 1995 Mar;56(3):608-15. Am J Hum Genet. 1995. PMID: 7887414 Free PMC article.
[Li-Fraumeni syndrome].
Frebourg T. Frebourg T. Bull Cancer. 1997 Jul;84(7):735-40. Bull Cancer. 1997. PMID: 9339200 Review. French.
p53 germline mutations in Li-Fraumeni syndrome.
Santibáñez-Koref MF, Birch JM, Hartley AL, Jones PH, Craft AW, Eden T, Crowther D, Kelsey AM, Harris M. Santibáñez-Koref MF, et al. Lancet. 1991 Dec 14;338(8781):1490-1. doi: 10.1016/0140-6736(91)92303-j. Lancet. 1991. PMID: 1683921
Pediatric cancer and Li-Fraumeni/Li-Fraumeni-like syndromes: a review for the pediatrician.
Giacomazzi CR, Giacomazzi J, Netto CB, Santos-Silva P, Selistre SG, Maia AL, Oliveira VZ, Camey SA, Goldim JR, Ashton-Prolla P. Giacomazzi CR, et al. Rev Assoc Med Bras (1992). 2015 May-Jun;61(3):282-9. doi: 10.1590/1806-9282.61.03.282. Rev Assoc Med Bras (1992). 2015. PMID: 26248253 Review.
Low rate of TP53 germline mutations in breast cancer/sarcoma families not fulfilling classical criteria for Li-Fraumeni syndrome.
Evans DG, Birch JM, Thorneycroft M, McGown G, Lalloo F, Varley JM. Evans DG, et al. J Med Genet. 2002 Dec;39(12):941-4. doi: 10.1136/jmg.39.12.941. J Med Genet. 2002. PMID: 12471212 Free PMC article. No abstract available.

See all similar articles

Cited by

Cancer risks from germline p53 mutations.
Frebourg T, Friend SH. Frebourg T, et al. J Clin Invest. 1992 Nov;90(5):1637-41. doi: 10.1172/JCI116034. J Clin Invest. 1992. PMID: 1430194 Free PMC article. Review. No abstract available.
Immunohistochemical Loss of the DNA Mismatch Repair Proteins MSH2 and MSH6 in Malignant Fibrous Histiocytomas.
Ericson K, Engellau J, Persson A, Lindblom A, Domanski H, Akerman M, Nilbert M. Ericson K, et al. Sarcoma. 2004;8(4):123-7. doi: 10.1155/2004/735237. Sarcoma. 2004. PMID: 18521406 Free PMC article.
Identification of a polymorphism in intron 2 of the p53 gene.
Pleasants LM, Hansen MF. Pleasants LM, et al. Hum Genet. 1994 May;93(5):607-8. doi: 10.1007/BF00202835. Hum Genet. 1994. PMID: 8168846
Polymorphism of the pentanucleotide repeat d(AAAAT) within intron 1 of the human tumor suppressor gene p53 (17p13.1).
Hahn M, Fislage R, Pingoud A. Hahn M, et al. Hum Genet. 1995 Apr;95(4):471-2. doi: 10.1007/BF00208983. Hum Genet. 1995. PMID: 7705850

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal